Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn’s disease. In these conditions, the body’s immune system attacks healthy tissues in the gut, causing abdominal pain, blood in the stool, and diarrhea.
People with Crohn’s and ulcerative colitis (UC) have chronic inflammation of the gut with an excess of white blood cells that target the gastrointestinal (GI) tract. The alpha-4-beta-7 T-cell attaches to the MAdCAM-1 receptor in the gut, causing increased inflammation.
Entyvio belongs to a class of drugs known as monoclonal antibodies and works by blocking this connection so that excess white blood cells can’t enter the gut tissue. Entyvio is very specialized to specifically target GI proteins only. When T-cells can’t enter the gut, inflammation is reduced as well as the symptoms of Crohn’s and UC.
Before your infusion, it is important to drink plenty of water and come to your appointment hydrated. Additionally, you must alert us as soon as possible to any changes in your insurance to ensure that we are still an in-network provider for your infusion therapy.
Your dedicated Infusion nurse will check your vitals and review your medical history to check for improvements or potential side effects of your infusion therapy.
Your nurse will begin your infusion and check in on you periodically during your treatment.
After your infusion, your nurse will monitor you for 30 minutes to ensure you do not have any complications or reactions to the infusion therapy.
Why patients choose Pure to receive their Entyvio infusion:
At Pure Infusion Suites®, we create an unmatched patient experience, improve healthcare outcomes and lower the cost of care.
Safe & Private Suites
Comfortable, private rooms with a relaxing, spa-like atmosphere
55” TVs with Netflix, Wifi, drinks, snacks, meals & more